Allgens Medical Technology CO., LTD. Stock

Equities

688613

CNE1000051W7

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
14.08 CNY +1.59% Intraday chart for Allgens Medical Technology CO., LTD. +8.06% -36.75%

Financials

Sales 2022 245M 33.85M 46.24M Sales 2023 226M 31.26M 42.7M Capitalization 2.97B 410M 560M
Net income 2022 95M 13.11M 17.91M Net income 2023 54M 7.45M 10.18M EV / Sales 2022 8.59 x
Net cash position 2022 1.01B 140M 191M Net cash position 2023 1.01B 139M 190M EV / Sales 2023 8.65 x
P/E ratio 2022
33 x
P/E ratio 2023
54.3 x
Employees 151
Yield 2022
0.46%
Yield 2023
-
Free-Float 55.86%
More Fundamentals * Assessed data
Dynamic Chart
Allgens Medical Technology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Allgens Medical Technology CO., LTD.(SHSE:688613) added to Shanghai Stock Exchange A Share Index CI
Allgens Medical Technology CO., LTD.(SHSE:688613) added to Shanghai Stock Exchange Composite Index CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Allgens Medical Technology CO., LTD. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
More news
1 day+1.59%
1 week+8.06%
Current month-7.43%
1 month-7.91%
3 months-26.13%
6 months-35.32%
Current year-36.75%
More quotes
1 week
13.17
Extreme 13.17
14.08
1 month
12.58
Extreme 12.58
15.78
Current year
12.44
Extreme 12.44
22.49
1 year
12.44
Extreme 12.44
29.80
3 years
12.44
Extreme 12.44
137.85
5 years
12.44
Extreme 12.44
137.85
10 years
12.44
Extreme 12.44
137.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 46 22-05-31
Director of Finance/CFO 46 22-11-28
Chairman 55 06-09-30
Members of the board TitleAgeSince
Director/Board Member 51 -
Chairman 55 04-11-30
Director/Board Member 81 04-11-30
More insiders
Date Price Change Volume
24-04-26 14.08 +1.59% 2,692,293
24-04-25 13.86 +1.09% 1,112,295
24-04-24 13.71 +1.48% 992,891
24-04-23 13.51 +2.43% 1,305,368
24-04-22 13.19 +1.23% 1,273,338

End-of-day quote Shanghai S.E., April 25, 2024

More quotes
Allgens Medical Technology Co Ltd is a China-based company principally engaged in the research and development, production and sales of high-end biomedical materials and related medical device products. The Company’s main products are mineralized collagen artificial bone repair products used in orthopedics, oral or plastic surgery, and neurosurgery, including Gejin and BonGold, which are mainly used for filling and regenerative repair of various bone defects in the orthopedics field. Chibei, which are mainly used for filling and regenerating bone defects in oral and orthopedic surgery. And Lurui, which are mainly used for cranial defect filling and regeneration repair in neurosurgery. The Company distributes its products both in the domestic market and to overseas markets.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688613 Stock